Physician profile
Michael Shafran
NPI 1134469992
$312.96
in general payments reported to CMS, 2019-2025
6 companies · $62.96 in 2025
The $62.96 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $31.18 · 2021: $18.57 · 2022: $19.70 · 2023: $26.15 · 2025: $62.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $152.93 | 2019-2020 | |
| Allergan, INC. | $51.53 | 2019-2022 | |
| Abbvie INC. | $51.34 | 2023-2025 | |
| Axogen | $37.77 | 2025 | |
| Merz North America, INC. | $12.72 | 2019 | |
| Apyx Medical Corporation | $6.67 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shafran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.